2016 |
Discovery of Stable Non-opioid Dynorphin A Analogues Interacting at the Bradykinin Receptors for the Treatment of Neuropathic Pain. |
Frank Porreca, PhD |
2016 |
Altering the Proteoglycan State of Transforming Growth Factor β Type III Receptor (TβRIII)/Betaglycan Modulates Canonical Wnt/β-Catenin Signaling. |
Nam Lee, Ph.D. |
2016 |
Effect of Reproductive History and Exogenous Hormone Use on Cognitive Function in Mid- and Late Life. |
Roberta Diaz Brinton, Ph.D |
2016 |
Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
2016 |
Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery. |
Jeffrey J. Lochhead, PhD |
2016 |
Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype. |
Roberta Diaz Brinton, Ph.D |
2016 |
Cyclic Opioid Peptides. |
|
2016 |
Triad of Risk for Late Onset Alzheimer's: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex. |
Roberta Diaz Brinton, Ph.D |
2016 |
Biphalin: The Foundation of Bivalent Ligands. |
|
2016 |
Regulation of gene expression and mitochondrial dynamics by SMAD. |
Nam Lee, Ph.D. |
2016 |
Enkephalin-Fentanyl Multifunctional Opioids as Potential Neuroprotectants for Ischemic Stroke Treatment. |
|
2016 |
Dynorphin A analogs for the treatment of chronic neuropathic pain. |
|
2015 |
Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes. |
Roberta Diaz Brinton, Ph.D |
2015 |
Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands. |
Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
2015 |
CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling. |
|
2015 |
Innovative qPCR using interfacial effects to enable low threshold cycle detection and inhibition relief. |
|
2015 |
Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivatives. |
Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
2015 |
Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury. |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
2015 |
Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain. |
Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
2015 |
Epigenetic Regulation of GDF2 Suppresses Anoikis in Ovarian and Breast Epithelia. |
Nam Lee, Ph.D. |
2015 |
Design, synthesis, and biological evaluation of a series of bifunctional ligands of opioids/SSRIs. |
|
2015 |
Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration. |
Jeffrey J. Lochhead, PhD |
2015 |
Mechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis. |
Todd Vanderah, PhD |
2015 |
Endoglin Regulation of Smad2 Function Mediates Beclin1 Expression and Endothelial Autophagy. |
Nam Lee, Ph.D. |
2015 |
Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif. |
John M. Streicher, PhD |